Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T Skarin

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Hematology/Oncology Clinics of North America|June 1, 1994
Use of tumor markers in lung cancerG M Strauss, A T Skarin
CA: a Cancer Journal for Clinicians|November 26, 1997
Non-Hodgkin's lymphomas: current classification and managementA T Skarin, D M Dorfman
Journal of Surgical Oncology|January 1, 1976
Patterns of serial CEA assays and their clinical use in management of colorectal cancerP H Sugarbaker, A T Skarin, N Zamcheck
JAMA|November 13, 1981
Carcinoembryonic antigen. A useful monitor of therapy of small cell lung cancerR H Goslin, A T Skarin, N Zamcheck
Archives of Pathology|March 1, 1972
Acute leukemia terminating in histiocytic medullary reticulosisA T Skarin, K Karb, E S Reynolds
Oncology|January 1, 1973
Muramidase activity in leukemia and myeloproliferative disordersA T Skarin, Y Matsuo, W C Moloney
Cancer|May 1, 1972
Muramidase in myeloproliferative disorders terminating in acute leukemiaA T Skarin, Y Matsuo, W C Moloney
Cancer Treatment and Research|February 28, 2001
Malignant pleural mesotheliomaL Ho, D J Sugarbaker, A T Skarin
Cancer|November 1, 1974
1,-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (methyl CCNU) and adriamycin combination therapyJ J Lokich, A T Skarin, E Frei
Cancer|August 1, 1978
Chemotherapy of the non-Hodgkin's lymphomasG P Canellos, T A Lister, A T Skarin
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Hematology/Oncology Clinics of North America|June 1, 1994
Use of tumor markers in lung cancerG M Strauss, A T Skarin
CA: a Cancer Journal for Clinicians|November 26, 1997
Non-Hodgkin's lymphomas: current classification and managementA T Skarin, D M Dorfman
Journal of Surgical Oncology|January 1, 1976
Patterns of serial CEA assays and their clinical use in management of colorectal cancerP H Sugarbaker, A T Skarin, N Zamcheck
JAMA|November 13, 1981
Carcinoembryonic antigen. A useful monitor of therapy of small cell lung cancerR H Goslin, A T Skarin, N Zamcheck
Archives of Pathology|March 1, 1972
Acute leukemia terminating in histiocytic medullary reticulosisA T Skarin, K Karb, E S Reynolds
Oncology|January 1, 1973
Muramidase activity in leukemia and myeloproliferative disordersA T Skarin, Y Matsuo, W C Moloney
Cancer|May 1, 1972
Muramidase in myeloproliferative disorders terminating in acute leukemiaA T Skarin, Y Matsuo, W C Moloney
Cancer Treatment and Research|February 28, 2001
Malignant pleural mesotheliomaL Ho, D J Sugarbaker, A T Skarin
Cancer|November 1, 1974
1,-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (methyl CCNU) and adriamycin combination therapyJ J Lokich, A T Skarin, E Frei
Cancer|August 1, 1978
Chemotherapy of the non-Hodgkin's lymphomasG P Canellos, T A Lister, A T Skarin
Pageof 10